DELFI Diagnostics, Inc. is developing next-generation, blood-based tests for early cancer detection.
DELFI Diagnostics, Inc. is developing next-generation, blood-based tests for early cancer detection. The company prioritizes solutions that can save lives on a global scale. This role will drive efforts to verify and validate the performance of an automated IVD Next-Generation Sequencing-based assay.
DELFI Diagnostics, Inc. is developing next-generation, blood-based tests for early cancer detection.
ARK Diagnostics, Inc.